Literature DB >> 11941586

[Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma].

Guang He1, Zhen Zhao, Weineng Fu, Xinghe Sun, Zhenming Xu, Kailai Sun.   

Abstract

OBJECTIVE: To investigate the role of transglutaminase 3 (TGM3) gene in laryngeal carcinogenesis.
METHODS: The authors detected the deletion indirectly through loss of heterozygosity (LOH) analysis at DNA level using 4 STR primers within and near TGM3 gene in 72 cases, and detected the differential expression of TGM3 gene in 8 cases of paired normal and cancerous tissue of laryngeal carcinoma by Northern blot.
RESULTS: LOH was found existing in all of the microsatellite loci, and the LOH frequencies were 25.76%, 20.00%, 38.10% and 18.75% at D20S17, D20S607, D20S99 and D20S841 respectively; LOH concerning at least one polymorphism locus accounted for 61.11%. No correlation of clinical stage, lymph node metastasis and differentiation with the LOH of TGM3 gene was observed, P>0.05. TGM3 gene expressed significantly higher in normal tissues than in paired cancerous tissues.
CONCLUSION: TGM3 gene might play an important role in laryngeal carcinogenesis and further researches will be needed to clarify the possible mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941586

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  5 in total

1.  Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.

Authors:  Wei Liu; Zai-Cheng Yu; Wen-Feng Cao; Fang Ding; Zhi-Hua Liu
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC).

Authors:  Sorour Shojaeian; Abdolkarim Moazeni-Roodi; Abdolamir Allameh; Ata Garajei; Anoshirvan Kazemnejad; Kourosh Kabir; Amir-Hassan Zarnani
Journal:  Avicenna J Med Biotechnol       Date:  2021 Apr-Jun

3.  Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.

Authors:  Seema Nayak; M L B Bhatt; Madhu Mati Goel; Seema Gupta; Abbas Ali Mahdi; Anupam Mishra; Divya Mehrotra
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

4.  TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.

Authors:  Xiangbing Wu; Wei Cao; Xu Wang; Jianjun Zhang; Zhongjing Lv; Xing Qin; Yadi Wu; Wantao Chen
Journal:  Mol Cancer       Date:  2013-12-01       Impact factor: 27.401

Review 5.  Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer.

Authors:  Elina S Chermnykh; Elena V Alpeeva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2020-08-30       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.